Efficacy and safety of once daily triamcinolone acetonide aqueous nasal spray in adults with non-allergic and allergic rhinitis

Allergologia et Immunopathologia

Volumn 41, Issue 6, 2013, Pages 374-380

  Baccioglu Kavut, A ^a   Kalpakllu, F ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Allergic rhinitis; Corticosteroid; IgE; Neurogenic; Non allergic rhinitis; Treatment; Triamcinolone

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; IMMUNOGLOBULIN E; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE ACETONIDE NASAL SPRAY; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ARTICLE; BITTER TASTE; CLINICAL ARTICLE; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NASAL BURNING; NASAL PRURITUS; NOSE DISEASE; NOSE MUCUS; NOSE OBSTRUCTION; PEAK NASAL INSPIRATORY FLOW; PRICK TEST; QUALITY OF LIFE; RHINORRHEA; SHORT FORM 36; SIDE EFFECT; SNORING; TOTAL NASAL SYMPTOM SCORE; VASOMOTOR RHINITIS;

ALLERGIC RHINITIS; CORTICOSTEROID; IGE; NEUROGENIC; NON-ALLERGIC RHINITIS; TREATMENT; TRIAMCINOLONE;

ADULT; ANTI-INFLAMMATORY AGENTS; CLINICAL PROTOCOLS; FEMALE; FOLLOW-UP STUDIES; HEADACHE; HUMANS; INSPIRATORY CAPACITY; MALE; MIDDLE AGED; NASAL SPRAYS; QUALITY OF LIFE; RHINITIS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; YOUNG ADULT;

EID: 84888844552     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2012.05.006     Document Type: Article

References (33)

1. Bousquet J., Khaltaev N., Cruz A.A., Denburg J., Fokkens W.J., Togias A., et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008, 63:8-160.
2. Kaliner M.A., Baraniuk J.N., Benninger M., Bernstein J.A., Lieberman P., Meltzer E.O., et al. Consensus definition of nonallergic rhinopathy, previously referred to as vasomotor rhinitis, nonallergic rhinitis, and/or idiopathic rhinitis. WAO J 2009, 2:119-120.
3. Kalpaklioglu A.F., Kavut A.B. Allergic and nonallergic rhinitis: can we find the differences/similarities between the two pictures?. J Asthma 2009, 46:481-485.
4. Kaliner M.A., Baraniuk J.N., Benninger M.S., Bernstein J.A., Lieberman P., Meltzer E.O., et al. Consensus description of inclusion and exclusion criteria for clinical studies of nonallergic rhinopathy (NAR), previously referred to as vasomotor rhinitis (VMR), nonallergic rhinitis, and/or idiopathic rhinitis. WAO J 2009, 2:180-184.
5. Powe D.G., Jagger C., Kleinjan A., Carney A.S., Jenkins D., Jones N.S. 'Entopy': localized mucosal allergic disease in the absence of systemic responses for atopy. Clin Exp Allergy 2003, 33:1374-1379.
6. Knipping S., Holzhausen H.J., Riederer A., Schrom T. Allergic and idiopathic rhinitis: an ultrastructural study. Eur Arch Otorhinolaryngol 2009, 266:1249-1256.
7. Webb D.R., Meltzer E.O., Finn A.F., Rickard K.A., Pepsin P.J., Westlund R., et al. Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia. Ann Allergy Asthma Immunol 2002, 88:385-390.
8. Salib R.J., Harries P.G., Nair S.B., Howarth P.H. Mechanisms and mediators of nasal symptoms in non-allergic rhinitis. Clin Exp Allergy 2008, 38:393-404.
9. van Rijswijk J.B., Blom H.M., KleinJan A., Mulder P.G., Rijntjes E., Fokkens W.J. Inflammatory cells seem not to be involved in idiopathic rhinitis. Rhinology 2003, 41:25-30.
10. Lieberman P. Treatment update: nonallergic rhinitis. Allergy Asthma Proc 2001, 22:199-202.
11. Scarupa M.D., Kaliner M.A. Non-allergic rhinitis, with a focus on vasomotor rhinitis. WAO J 2009, 2:20-25.
12. Piedimonte G., McDonald D.M., Nadel J.A. Glucocorticoids inhibit neurogenic plasma extravasation and prevent virus-potentiated extravasation in the rat trachea. J Clin Invest 1990, 86:1409-1415.
13. Leynaert B., Neukirch C., Liard R., Bousquet J., Neukirch F. Quality of life in allergic rhinitis and asthma: a population-based study of young adults. Am J Respir Crit Care 2000, 162:1391-1396.
14. Kalpaklioǧlu A.F., Baccioǧlu A. Evaluation of quality of life: impact of allergic rhinitis on asthma. J Clin Invest 2008, 18:168-173.
15. Kalpaklioglu A.F., Kavut A.B., Ekici M. Allergic and nonallergic rhinitis: the threat for obstructive sleep apnea. Ann Allergy Asthma Immunol 2009, 103:20-25.
16. Baroody F.M., Mucha S.M., Detineo M., Naclerio R.M. Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol 2008, 121:1126-1132.
17. Ware J.E., Sherbourne C.D. The MOS 36-item short-form survey (SF-36) I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
18. Juniper E.F., Thompson A.K., Ferrie P.J., Roberts J.N. Development and validation of mini rhinoconjunctivitis quality of life questionnaire. Clin Exp Allergy 2000, 30:132-140.
19. Johns M.W. Reliability and factor analysis of the epworth sleepiness scale. Sleep 1992, 15:376-381.
20. Scadding G.K., Lund V.J., Jacques L.A., Richards D.H. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy 1995, 25:737-743.
21. Lundblad L., Sipila P., Farstad T., Drozdziewicz D. Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol 2001, 121:505-509.
22. Day J.H., Andersson C.B., Briscoe M.P. Efficacy and safety of intranasal budesonide in the treatment of perennial rhinitis in adults and children. Ann Allergy 1990, 64:445-450.
23. Kalpaklioglu A.F., Kavut A.B. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis. Am J Rhinol Allergy 2010, 24:29-33.
24. Rondon C., Romero J.J., Lopez S., Antunez C., Martin-Casanez E., Torres M.J., et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol 2007, 119:899-905.
25. Wedback A., Enbom H., Eriksson N.E., Moverare R., Malcus I. Seasonal non-allergic rhinitis (SNAR)-a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent non-allergic rhinitis. Rhinology 2005, 43:86-92.
26. Pfaar O., Raap U., Holz M., Hörmann K., Klimek L. Pathophysiology of itching and sneezing in allergic rhinitis. Swiss Med Wkly 2009, 139:35-40.
27. Bernstein J.A. Characteristics of nonallergic vasomotor rhinitis. WAO J 2009, 2:102-105.
28. Starling-Schwanz R., Peake H.L., Salome C.M., Toelle B.G., Ng K.W., Marks G.B., et al. Repeatability of peak nasal inspiratory flow measurements and utility for assessing the severity of rhinitis. Allergy 2005, 60:795-800.
29. Blom H.M., Godthelp T., Fokkens W.J., KleinJan A., Mulder P.G., Rijntjes E. The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic, noninfectious perennial rhinitis. J Allergy Clin Immunol 1997, 100:739-747.
30. Jacobs R., Lieberman P., Kent E., Silvey M., Locantore N., Philpot E.E. Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment. Allergy Asthma Proc 2009, 30:120-127.
31. Reynolds P.N., Holmes M.D., Scicchitano R. Role of tachykinins in bronchial hyper-responsiveness. Clin Exp Pharmacol Physiol 1997, 24:273-280.
32. Baccioglu Kavut A., Kalpaklioglu A.F., Atasoy P. Which is the current hypothesis for idiopathic rhinitis; allergic or neurogenic?. Allergy 2010, 65:152.
33. Meltzer E.O., Munafo D.A., Chung W., Gopalan G., Varghese S.T. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. Ann Allergy Asthma Immunol 2010, 105:65-74.